A review of insurance policies for Demodex blepharitis treatments, along with an analysis of the potential toxicities associated with these treatments. This is a video synopsis/summary of an Insights ...

Credit: Tarsus Pharmaceuticals. Xdemvy is supplied as an ophthalmic solution containing lotilaner 0.25% (2.5mg/mL) in a 10mL bottle; it is expected to be available by the end of August 2023. The Food ...

Elizabeth Yeu, MD, provides a comprehensive overview of Demodex blepharitis stemming from infestations of eyelash follicle mites. In this video segment featuring Dr. Elizabeth Yeu, an expert in ...

Demodex blepharitis is more common than most people realize—but with the right treatment, it doesn’t have to be a lifelong nuisance. “You only get one pair of eyes,” Dr. Yeu says. “And this is one ...

Xdemvy (lotilaner ophthalmic solution 0.25%) is a medicine designed to treat Demodex blepharitis, a common but often overlooked eye condition caused by microscopic insects called Demodex mites on the ...

Please provide your email address to receive an email when new articles are posted on . Demodex blepharitis is so common that it makes up more than two thirds of all blepharitis cases. In fact, nearly ...

Credit: Tarsus Pharmaceuticals. Xdemvy is supplied as an ophthalmic solution containing lotilaner 0.25% (2.5mg/mL) in a 10mL bottle. Xdemvy ™ (lotilaner ophthalmic solution) is now available for the ...